**Chapter 9**

*Inflammatory Heart Diseases*

Current concept and clinical

Gynecology. 1989;**32**:54-67

Medicine. 2000;**342**:1077

Gynecology. 2012;**120**:1013

et al. Pregnancy-associated

[38] Tepper NK, Paulen ME, Marchbanks PA, Curtis KM. Safety of contraceptive use among women with peripartum cardiomyopathy: A systematic review. Contraception.

2010;**82**:95

Failure. 2009;**15**:645

[36] Goland S, Modi K, Bitar F, et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. Journal of Cardiac

[37] Elkayam U, Akhter MW, Singh H,

cardiomyopathy: Clinical characteristics and a comparison between early and late presentation. Circulation. 2005;**111**:2050

[33] Lee W, Cotton DB. Cardiomyopathy:

[34] Felker CM, Thompson RE, Hare JM, et al. The New England Journal of

[35] Harper MA, Meyer RE, Berg CJ. Peripartum cardiomyopathy: Population-based birth prevalence and 7-year mortality. Obstetrics and

management. Clinical Obstetrics and

**124**
